These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


202 related items for PubMed ID: 20180636

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH, Poilvache P, Van Egeren A, Devogelaer JP, Lenz ME, Thonar EJ.
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [Abstract] [Full Text] [Related]

  • 24. Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis.
    O'Hara R, Murphy EP, Whitehead AS, FitzGerald O, Bresnihan B.
    Arthritis Rheum; 2004 Jun; 50(6):1788-99. PubMed ID: 15188355
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of interleukin-1alpha-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors: potential role for matrix metalloproteinases in the generation of cartilage oligomeric matrix protein fragments in arthritic synovial fluid.
    Ganu V, Goldberg R, Peppard J, Rediske J, Melton R, Hu SI, Wang W, Duvander C, Heinegård D.
    Arthritis Rheum; 1998 Dec; 41(12):2143-51. PubMed ID: 9870871
    [Abstract] [Full Text] [Related]

  • 26. A remarkable increase of superoxide dismutase activity in synovial fluid of patients with rheumatoid arthritis.
    Igari T, Kaneda H, Horiuchi S, Ono S.
    Clin Orthop Relat Res; 1982 Dec; (162):282-7. PubMed ID: 7067225
    [Abstract] [Full Text] [Related]

  • 27. The effects of interferon-beta treatment of synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis.
    Smeets TJ, Dayer JM, Kraan MC, Versendaal J, Chicheportiche R, Breedveld FC, Tak PP.
    Arthritis Rheum; 2000 Feb; 43(2):270-4. PubMed ID: 10693865
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production.
    Zhu P, Ding J, Zhou J, Dong WJ, Fan CM, Chen ZN.
    Arthritis Res Ther; 2005 Feb; 7(5):R1023-33. PubMed ID: 16207318
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study.
    Peake NJ, Khawaja K, Myers A, Jones D, Cawston TE, Rowan AD, Foster HE.
    Rheumatology (Oxford); 2005 Nov; 44(11):1383-9. PubMed ID: 16049050
    [Abstract] [Full Text] [Related]

  • 32. Cysteine and serine proteases of synovial tissue in rheumatoid arthritis and osteoarthritis.
    Solau-Gervais E, Zerimech F, Lemaire R, Fontaine C, Huet G, Flipo RM.
    Scand J Rheumatol; 2007 Nov; 36(5):373-7. PubMed ID: 17963167
    [Abstract] [Full Text] [Related]

  • 33. The detection, quantification and partial characterisation of cathepsin B-like activity in human pathological synovial fluids.
    Duffy JM, Walker B, Guthrie D, Grimshaw J, McNally G, Grimshaw JT, Spedding PL, Mollan RA.
    Eur J Clin Chem Clin Biochem; 1994 Jun; 32(6):429-34. PubMed ID: 7918840
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cathepsin cysteine proteases in cardiovascular disease.
    Lutgens SP, Cleutjens KB, Daemen MJ, Heeneman S.
    FASEB J; 2007 Oct; 21(12):3029-41. PubMed ID: 17522380
    [Abstract] [Full Text] [Related]

  • 36. Proteolytic enzymes in joint destruction.
    Peltonen L, Puranen J, Lehtinen K, Korhonen LK.
    Scand J Rheumatol; 1981 Oct; 10(2):107-14. PubMed ID: 7017914
    [Abstract] [Full Text] [Related]

  • 37. Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis.
    Cunnane G, FitzGerald O, Hummel KM, Gay RE, Gay S, Bresnihan B.
    Rheumatology (Oxford); 1999 Jan; 38(1):34-42. PubMed ID: 10334680
    [Abstract] [Full Text] [Related]

  • 38. Protease expression in interface tissues around loose arthroplasties.
    Kido A, Pap G, Nägler DK, Ziomek E, Ménard R, Neumann HW, Roessner A.
    Clin Orthop Relat Res; 2004 Aug; (425):230-6. PubMed ID: 15292813
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.